BEIJING, Dec 15 — Chinese biotech company BeiGene Ltd plunged on its Shanghai debut today after raising US$3.5 billion in the biggest STAR Market listing this year.
BeiGene’s Nasdaq-listed shares have tumbled nearly 20 per cent so far this month, as US securities regulators finalished rules to kick non-compliant Chinese companies off American exchanges in three years — a risk BeiGene flagged in its Shanghai share sale prospecutus. BeiGene’s Hong Kong-traded shares lost over 4 per cent today, having also tumbled one fifth this month.
Just like COVID experimental Vaccine, the evil corrupt politicians were exposed
Sverige Senaste nytt, Sverige Rubriker
Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.
Källa: malaymail - 🏆 1. / 86 Läs mer »